Human Recombinant CCL4 (MIP-1B) (from E. coli)

Supplier: CHEMOTACTICS, INC MS

CCL4-100UG CCL4-1MG CCL4-50UG
MSPP-CCL4100UGEA 761.56 CAD
MSPP-CCL4100UG MSPP-CCL41MG MSPP-CCL450UG
Human Recombinant CCL4 (MIP-1B) (from E. coli)
Proteins and Peptides

Recombinant Human CCL4 (MIP-1B) in lyopholized format with very low endotoxin levels.


  • Extremely low endotoxin levels (<0.01 EU per 1 μg)
  • Functional activity tested and validated
  • For use in various streptavidin applications: Flow cytometry, microscopy, and other imaging techniques


Monokine with inflammatory and chemokinetic properties. Binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-beta induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-beta(3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T-cells. MIP-1-beta(3-69) is also a ligand for CCR1 and CCR2 isoform B.


Ordering information: Larger sizes available, please request a custom quote.


Delivery information: Shipped lyophilized at room temperature.


Caution: For research use only, not for use in humans.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR